id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-0775-0039,FDA,FDA-2021-D-0775,Content of Premarket Submissions for Device Software Functions; Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2023-06-14T04:00:00Z,2023,6,2023-06-14T04:00:00Z,,2025-11-27T10:00:15Z,,1,0,0900006485b18ca6
FDA-2021-D-0775-0038,FDA,FDA-2021-D-0775,Content of Premarket Submissions for Device Software Functions; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2023-06-14T04:00:00Z,2023,6,2023-06-14T04:00:00Z,,2023-06-14T12:45:54Z,2023-12723,0,0,0900006485b18f95
FDA-2021-D-0775-0002,FDA,FDA-2021-D-0775,Content of Premarket Submissions for Device Software Functions - Draft Guidance for Industry,Other,Guidance,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,,2023-06-14T14:35:56Z,,0,0,0900006484e1b757
FDA-2021-D-0775-0001,FDA,FDA-2021-D-0775,"Content of Premarket Submissions for Device Software Functions; Draft
Guidance for Industry and Food and Drug Administration Staff; Availability",Notice,Notice of Availability,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,2022-02-03T04:59:59Z,2022-03-11T02:00:35Z,2021-24061,0,0,0900006484e17ebe